Tehreen Parveen: Historical Milestone in Drug Discovery – The Discovery of Aspirin
Tehreen Parveen, Assistant Professor at RIMT University, shared a post on LinkedIn:
“Historical Milestone in Drug Discovery: The Discovery of Aspirin
Few medicines have had as profound an impact on global healthcare as aspirin.
What began as a traditional remedy derived from willow bark evolved into one of the most widely used and studied drugs in medical history. In 1897, chemist Felix Hoffmann developed a more stable and tolerable form of acetylsalicylic acid, paving the way for the medicine we know today as aspirin.
Why Aspirin Changed Medicine
- Revolutionized pain and fever management
- Became a cornerstone treatment for inflammation
- Opened new avenues in medicinal chemistry
- Continues to play a vital role in cardiovascular disease prevention
- Demonstrated how natural products can inspire transformative medicines
A Journey Through Time
- Ancient civilizations used willow bark to relieve pain and fever.
- 1828 – Salicin, the active compound, was isolated from willow bark.
- 1853 – Salicylic acid was synthesized, though it often caused stomach irritation.
- 1897 – Felix Hoffmann developed acetylsalicylic acid, creating a safer and more effective compound.
- 1899 – Aspirin was introduced commercially and went on to become one of the world’s most trusted medicines.
More than a century later, aspirin remains a powerful example of how scientific innovation can transform traditional knowledge into a medicine that improves millions of lives.
From willow bark to modern medicine, aspirin’s story is a testament to the enduring impact of drug discovery.”

Stay updated with Hemostasis Today.
-
Jun 29, 2026, 06:33Andreas Calatzis: Can Fibrinolysis Sensitivity Be Claimed Without a Reference Standard
-
Jun 29, 2026, 06:25Aliaa Albadri: When a Hair Wash Leads to a Stroke Workup
-
Jun 29, 2026, 06:16Muhammad Sufyan: Deep Vein Thrombosis – Recognizing the Warning Signs
-
Jun 29, 2026, 05:33Janak Sadhu: Uniting for The Stroke-Free Mehsana Initiative
-
Jun 29, 2026, 05:20Deepti Sachan: A Global Exchange Shaping the Future of Transfusion Medicine at ISBT 2026
-
Jun 29, 2026, 04:50Scott Cameron: ACC/AHA Guidance on Acute Pulmonary Embolism Management
-
Jun 29, 2026, 03:10Aryabhatta Sadhu: ABO and Rh Incompatibility In Stem Cell Transplantation
-
Jun 29, 2026, 02:41Arun V. J.: ISBT Is Where the Future of Transfusion Medicine Begins
-
Jun 29, 2026, 02:41Manish Raturi: Does Patient Type Matter in Massive Blood Transfusion?